Beijing Chinese Medicine Hospital-Pinggu Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2018
NCT04296825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Chinese Medicine Hospital-Pinggu Hospital | Beijing Traditional Chinese Medicine Hospital Pinggu Hospital

Active Ingredients

Drugs in Phase 1 Trials (3)

bifidobacterium animalis (1 trial)

camel milk (1 trial)

cow milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3